Saskia Middeldorp
Saskia Middeldorp is an expert in Hematology at Radboud University Nijmegen Medical Centre (Netherlands). As of November 2026, ScienceLeadR ranks Saskia Middeldorp in the top 1% of experts worldwide for Embolism and Thrombosis and Pulmonary Embolism. Saskia Middeldorp has authored 604 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 4 of them ongoing. SLR score: 2,041 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Cardiology - Public Health - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
- Top Embolism and Thrombosis key opinion leaders — ranked #24
Organizations
Career arc: 1998 - 2026
Number : 604
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome. PMID 42674367 — complement c2, orosomucoid, antiphospholipid syndrome, glycoproteins, proteomics, complement system proteins, thrombosis, proteome, blood proteins, plasma | J Thromb Haemost | 2026 | 0 |
| Socioeconomic status and its association with venous thromboembolism during pregnancy and postpartum: results from a Dutch population-based study. PMID 42595052 — pregnancy, thromboembolism, income, survival analysis, venous thromboembolism, thrombosis, social class, education, postpartum period, demography | J Thromb Haemost | 2026 | 0 |
| It is time to accept the painful truth: low-molecular-weight heparin does not improve outcomes in women with pregnancy complications. PMID 42963176 — pregnancy, heparin, pregnancy complications, thrombosis, heparin, low-molecular-weight | J Thromb Haemost | 2026 | 0 |
| Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial. PMID 42708556 — cerebral hemorrhage, hemorrhage, hematoma, antithrombin iii, factor xa inhibitors, factor xa | Ann Neurol | 2026 | 0 |
| Antiphospholipid antibodies and cardiovascular thrombosis. PMID 41807758 — antibodies, antiphospholipid, anticoagulants, antibodies, cardiovascular diseases, antiphospholipid syndrome, lupus coagulation inhibitor, research, thrombosis, phospholipids | Nat Rev Cardiol Top journal | 2026 | 8 |
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 8
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Leiden Thrombosis Recurrence Risk Prevention NCT06087952 — anticoagulants, thromboembolism, embolism, hemorrhage, venous thrombosis, pulmonary embolism, therapeutics, venous thromboembolism, thrombosis, veins | N/A | Active not recruiting | 2021 |
| Observational Dutch Young Symptomatic StrokE studY nEXT NCT05853796 — cerebral hemorrhage, embolism, hemorrhage, blood, ischemic stroke, stroke, cardiovascular diseases, thrombophilia, aged, cerebrovascular disorders, embolism and thrombosis, therapeutics, thrombosis, blood platelets, prognosis, hemostasis | N/A | Recruiting | 2023 |
| Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis NCT04660747 — sample size, anticoagulants, safety, hemorrhage, vitamins, venous thrombosis, duration of therapy, vitamin k, physicians, diagnosis, sinus thrombosis, intracranial, therapeutics, thrombosis, direct-acting oral anticoagulants | N/A | Recruiting | 2021 |
| Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine NCT04507178 — quality of life, health care costs, mortality, hemorrhage, brain, aneurysm, hospital mortality, subarachnoid hemorrhage, brain ischemia, therapeutics, nadroparin, heparin, low-molecular-weight, cerebral infarction, ischemia, hydrocephalus | Phase 2 | Recruiting | 2022 |
LeadR Networks
Main global connection map